ACAT1 and neoplasm: ACAT inhibition of TCR-gene-modified T cells similarly enhanced the production of other immune mediators with potential anti-tumour effects (TNF, MIP1β by intracellular cytokine staining, Supplementary Fig. 4n, o; TNF, MIP1β, Flt-3L, CD40L by Luminex, Supplementary Fig. 4m).